are glp-1 specialty drugs utilization isn't slowing down—and employers feeling the impact. In our latest pharmacy trend analysis, 7 of the top 10 non-specialty by spend were antidiabetic or weight management… What to Make of the
Description
doi: 10.1016/j.jdiacomp.2016.10.001
With your exercise, getting good sleep
As most discontinuations occurred during the rapid dose-escalation period of treatment, slower up-titration of dose may counter these
The absence of a control group precludes definitive conclusions on causality between GLP-1 receptor agonist therapy and observed outcomes, and residual confounding cannot be excluded In conclusion, arGLP-1 represent a valuable addition to the therapeutic arsenal for managing IWL or WR after BS
When Is Nausea Worst for GLP-1 Users
